Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Russ B Altman

Showing results (411-420 of 421) with videos related to

Pageof 43
Sort By:
Lancet (London, England)|May 4, 2010
Clinical assessment incorporating a personal genomeEuan A Ashley, Atul J Butte, Matthew T Wheeler, et al.
Frontiers in Psychiatry|March 22, 2018
Association of the Polygenic Scores for Personality Traits and Response to Selective Serotonin Reuptake Inhibitors in Patients with Major Depressive DisorderAzmeraw T Amare, Klaus Oliver Schubert, Fasil Tekola-Ayele, et al.
Plos Genetics|September 22, 2011
Phased whole-genome genetic risk in a family quartet using a major allele reference sequenceFrederick E Dewey, Rong Chen, Sergio P Cordero, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|January 6, 2019
The association of obesity and coronary artery disease genes with response to SSRIs treatment in major depressionAzmeraw T Amare, Klaus Oliver Schubert, Fasil Tekola-Ayele, et al.
Cell|March 20, 2012
Personal omics profiling reveals dynamic molecular and medical phenotypesRui Chen, George I Mias, Jennifer Li-Pook-Than, et al.
Lancet (London, England)|June 13, 2013
Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association studyMinoli A Perera, Larisa H Cavallari, Nita A Limdi, et al.
American Heart Journal|April 15, 2018
Genome-wide and candidate gene approaches of clopidogrel efficacy using pharmacodynamic and clinical end points-Rationale and design of the International Clopidogrel Pharmacogenomics Consortium (ICPC)Thomas O Bergmeijer, Jean-Luc Reny, Ruth E Pakyz, et al.
Human Mutation|June 22, 2017
Working toward precision medicine: Predicting phenotypes from exomes in the Critical Assessment of Genome Interpretation (CAGI) challengesRoxana Daneshjou, Yanran Wang, Yana Bromberg, et al.
Clinical Pharmacology and Therapeutics|May 31, 2020
Genomewide Association Study of Platelet Reactivity and Cardiovascular Response in Patients Treated With Clopidogrel: A Study by the International Clopidogrel Pharmacogenomics ConsortiumShefali Setia Verma, Thomas O Bergmeijer, Li Gong, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|September 11, 2019
Pharmacogenomic polygenic response score predicts ischaemic events and cardiovascular mortality in clopidogrel-treated patientsJoshua P Lewis, Joshua D Backman, Jean-Luc Reny, et al.
Pageof 43

Showing results (411-420 of 421) with videos related to

Sort By:
Pageof 43
Lancet (London, England)|May 4, 2010
Clinical assessment incorporating a personal genomeEuan A Ashley, Atul J Butte, Matthew T Wheeler, et al.
Frontiers in Psychiatry|March 22, 2018
Association of the Polygenic Scores for Personality Traits and Response to Selective Serotonin Reuptake Inhibitors in Patients with Major Depressive DisorderAzmeraw T Amare, Klaus Oliver Schubert, Fasil Tekola-Ayele, et al.
Plos Genetics|September 22, 2011
Phased whole-genome genetic risk in a family quartet using a major allele reference sequenceFrederick E Dewey, Rong Chen, Sergio P Cordero, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|January 6, 2019
The association of obesity and coronary artery disease genes with response to SSRIs treatment in major depressionAzmeraw T Amare, Klaus Oliver Schubert, Fasil Tekola-Ayele, et al.
Cell|March 20, 2012
Personal omics profiling reveals dynamic molecular and medical phenotypesRui Chen, George I Mias, Jennifer Li-Pook-Than, et al.
Lancet (London, England)|June 13, 2013
Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association studyMinoli A Perera, Larisa H Cavallari, Nita A Limdi, et al.
American Heart Journal|April 15, 2018
Genome-wide and candidate gene approaches of clopidogrel efficacy using pharmacodynamic and clinical end points-Rationale and design of the International Clopidogrel Pharmacogenomics Consortium (ICPC)Thomas O Bergmeijer, Jean-Luc Reny, Ruth E Pakyz, et al.
Human Mutation|June 22, 2017
Working toward precision medicine: Predicting phenotypes from exomes in the Critical Assessment of Genome Interpretation (CAGI) challengesRoxana Daneshjou, Yanran Wang, Yana Bromberg, et al.
Clinical Pharmacology and Therapeutics|May 31, 2020
Genomewide Association Study of Platelet Reactivity and Cardiovascular Response in Patients Treated With Clopidogrel: A Study by the International Clopidogrel Pharmacogenomics ConsortiumShefali Setia Verma, Thomas O Bergmeijer, Li Gong, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|September 11, 2019
Pharmacogenomic polygenic response score predicts ischaemic events and cardiovascular mortality in clopidogrel-treated patientsJoshua P Lewis, Joshua D Backman, Jean-Luc Reny, et al.
Pageof 43